Publications by authors named "Micaela Laber"
Am J Manag Care
February 2023
Article Synopsis
- AbbVie's adalimumab (Humira) is the world's top-selling drug, prompting a 2019 investigation by the US House Committee on Oversight and Accountability into its pricing and marketing practices due to concerns about public healthcare costs.
- The investigation highlights how legal tactics like patent thickets, evergreening, and product hopping enable pharmaceutical companies to maintain market dominance and limit competition.
- The analysis suggests that policy reforms and legal changes are necessary to combat these anti-competitive behaviors and improve access to more affordable treatment options like biosimilars.
